BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2014
View Archived Issues
FDA grants triheptanoin orphan drug status for GLUT-1 deficiency syndrome
Read More
Researchers use germline DNA gene editing to prevent muscular dystrophy in mice
Read More
Development of a receptor tyrosine kinase decoy as a potential anticancer therapy
Read More
Clenbuterol earns FDA orphan drug designation as adjunctive therapy for Pompe's disease
Read More
Papillary thyroid carcinoma predisposition linked to a mutation in the SRRM2 gene
Read More
IL28B gene polymorphisms examined in chronic hepatitis B
Read More
Triphase expands collaboration with Celgene
Read More
Ventana Medical Systems to develop companion diagnostics for ImmunoGen
Read More
New gene linked to Charcot-Marie-Tooth disease
Read More
Novartis reflects on accomplishments of third quarter 2014
Read More
Bristol-Myers Squibb reports new HIV integrase inhibitors
Read More
PATH reports on phase I/IIb study of ACE-527 ETEC vaccine
Read More
Osteros Biomedica begins phase I trial of MBC-11
Read More
Shire reports pipeline progress of third quarter 2014
Read More
Saniona acquires obesity candidate from NeuroSearch
Read More
Cara Therapeutics reports data from CR-845 trial
Read More
Dr. Falk Pharma enrolls first patients in phase III trial of LT-02
Read More
FDA grants accelerated approval to Trumenba for prevention of meningococcal meningitis B
Read More
FDA approves Xigduo XR for type 2 diabetes
Read More
FDA grants fast track designation to Novavax's H7N9 VLP vaccine candidate
Read More
Alkem and Georgetown University patent Flavivirus protease inhibitors
Read More
New LpxC inhibitors reported by Achaogen
Read More
GW Pharmaceuticals initiates phase II/III study of Epidiolex for Dravet syndrome
Read More
Roche patents new BTK inhibitors
Read More
Quanticel Pharmaceuticals presents new histone demethylase inhibitors
Read More
Imago Biosciences reports new KDM1A inhibitors
Read More
